MICOS10: Key Protein in MICOS Complex and Potential Drug Target

Target Name: MICOS10

NCBI ID: G440574

MICOS10

MICOS10: Key Protein in MICOS Complex and Potential Drug Target

MICOS10, also known as MICOS complex subunit MIC10, is a protein that is expressed in various tissues and cells throughout the body. It is a key component of the MICOS complex, which is a protein-protein interaction network that plays a crucial role in various cellular processes, including cell signaling, DNA replication, and chromatin structure. MICOS10 has also been shown to be a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The MICOS complex is a protein-protein interaction network that consists of multiple subunits that are involved in the regulation of various cellular processes. The MICOS complex plays a crucial role in the regulation of cell signaling, as it allows for the interactions between various signaling molecules and the cytoskeleton. MICOS10 is one of the key subunits of the MICOS complex and is involved in the regulation of several cellular processes, including cell signaling, DNA replication, and chromatin structure.

MICOS10 is a protein that is expressed in various tissues and cells throughout the body, including the brain, heart, liver, and muscle. It is a key component of the MICOS complex and is involved in the regulation of several cellular processes, including cell signaling, DNA replication, and chromatin structure. MICOS10 has also been shown to be expressed in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of MICOS10 is its role in the regulation of cell signaling. MICOS10 is involved in the regulation of several signaling pathways, including the TGF-β pathway, which is involved in the regulation of cell growth, differentiation, and survival. MICOS10 is also involved in the regulation of the PI3K/Akt signaling pathway, which is involved in the regulation of cell signaling and survival.

In addition to its role in cell signaling, MICOS10 is also involved in the regulation of DNA replication. MICOS10 is a key component of the MICOS complex, which is involved in the regulation of DNA replication during the S phase of cell division. MICOS10 plays a crucial role in the regulation of the initiation of DNA replication, as it is involved in the formation of the RNA double helix that serves as the template for DNA replication.

MICOS10 is also involved in the regulation of chromatin structure. MICOS10 is a key component of the MICOS complex, which is involved in the regulation of chromatin structure and the expression of gene products. MICOS10 plays a crucial role in the regulation of the organization of chromatin during the S phase of cell division, as it is involved in the formation of the heterochromatin fraction that is composed of coiled chromatin.

In conclusion, MICOS10 is a protein that is involved in the regulation of several cellular processes, including cell signaling, DNA replication, and chromatin structure. Its role in these processes makes it a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the functions of MICOS10 and its potential as a drug target and biomarker.

Protein Name: Mitochondrial Contact Site And Cristae Organizing System Subunit 10

Functions: Component of the MICOS complex, a large protein complex of the mitochondrial inner membrane that plays crucial roles in the maintenance of crista junctions, inner membrane architecture, and formation of contact sites to the outer membrane

The "MICOS10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MICOS10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets